IMAC (NASDAQ:BACK – Get Rating) and Acadia Healthcare (NASDAQ:ACHC – Get Rating) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability.
Volatility & Risk
IMAC has a beta of -0.64, suggesting that its stock price is 164% less volatile than the S&P 500. Comparatively, Acadia Healthcare has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500.
Get IMAC alerts:Profitability
This table compares IMAC and Acadia Healthcare's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| IMAC | -64.22% | -57.75% | -37.44% |
| Acadia Healthcare | 11.32% | 10.34% | 5.52% |
Institutional & Insider Ownership
21.9% of IMAC shares are held by institutional investors. Comparatively, 99.8% of Acadia Healthcare shares are held by institutional investors. 10.0% of IMAC shares are held by company insiders. Comparatively, 1.9% of Acadia Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.Analyst Recommendations
This is a summary of current ratings and recommmendations for IMAC and Acadia Healthcare, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| IMAC | 0 | 0 | 0 | 0 | N/A |
| Acadia Healthcare | 0 | 1 | 3 | 0 | 2.75 |
IMAC presently has a consensus target price of $5.00, suggesting a potential upside of 1,202.08%. Acadia Healthcare has a consensus target price of $83.88, suggesting a potential upside of 9.33%. Given IMAC's higher probable upside, equities analysts clearly believe IMAC is more favorable than Acadia Healthcare.
Earnings & Valuation
This table compares IMAC and Acadia Healthcare's top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| IMAC | $14.39 million | 0.73 | -$10.54 million | N/A | N/A |
| Acadia Healthcare | $2.31 billion | 3.01 | $190.63 million | $3.05 | 25.15 |
Acadia Healthcare has higher revenue and earnings than IMAC.
Summary
Acadia Healthcare beats IMAC on 9 of the 11 factors compared between the two stocks.
About IMAC
(Get Rating)
IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.
About Acadia Healthcare
(Get Rating)
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.
Receive News & Ratings for IMAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAC and related companies with MarketBeat.com's FREE daily email newsletter.